Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 529-535

  Razzouk, Bassem I ^b   Srinivas, Shamala ^b   Sample, Clare E ^b   Singh, Vivekanand ^b   Sixbey, John W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; BURKITT LYMPHOMA; DNA DETERMINATION; DNA RECOMBINATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; VIRUS RECOMBINATION;

EID: 0030020804     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.529     Document Type: Article

References (12)

1. Young LS. Epstein-Barr virus: general features. In: Webster RG, Granoff A, eds. Encyclopedia of virology. San Diego: Academic Press, 1994:404-10.
2. Pagano JS, Huang CH, Levine P. Absence of Epstein-Barr viral DNA in American Burkitt's lymphoma. N Engl J Med 1973;289:1395-9.
3. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Stemberg cells of Hodgkin's disease. N Engl J Med 1989;320:502-6.
4. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994; 68:6069-73.
5. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 1983;302: 21-4.
6. Pulvertaft RJV. Cytology of Burkitt's tumour (African lymphoma). Lancet 1964; 1:238-40.
7. Rabson M, Heston L, Miller G. Identification of a rare Epstein-Barr virus variant which enhances early antigen expression in Raji cells. Proc Natl Acad Sci USA 1983; 80:2762-6.
8. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 1984;33:27-32.
9. Miller G, Robinson J, Heston L, Lipman M. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc Natl Acad Sci USA 1974;71: 4006-10.
10. King W, Thomas-Powell AL, Raab-Traub N, Hawke M, Kieff E. EpsteinBarr virus RNA: V. Viral RNA in a restringently infected, growth-transformed cell line. J Virol 1980:36:506-18.
11. Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11:599-620.
12. Young LS, Lau R, Rowe M, et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 1991;65:2868-74.